Screener
D&A at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by National Health Investors in its filing.
Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.
The source filing: National Health Investors’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000877860-26-000135
| Line item | Three Months Ended / March 31, 2026 | 2025 |
|---|---|---|
| Interest and other income | 4,920 | 6,491 |
| Total revenues | 115,130 | 89,296 |
| Expenses: | ||
| Depreciation and amortization | 23,691 | 19,157 |
| Interest expense | 15,040 | 14,337 |
| Senior housing operating expenses | 28,169 | 10,853 |
| Legal expense | 305 | 1,426 |
| Franchise, excise and other taxes | 215 | 269 |
Item 1. Financial Statements
FAQ
- What is National Health Investors's D&A?
- National Health Investors (NHI) reported D&A of $23.69M in Q1 2026.
- How has National Health Investors's D&A changed year-over-year?
- National Health Investors's D&A increased by 23.7% year-over-year, from $19.16M to $23.69M.
- What is the long-term trend for National Health Investors's D&A?
- Over 4 years (2021 to 2025), National Health Investors's D&A has grown at a 0.0% compound annual growth rate (CAGR), from $80.8M to $80.94M.
- What does D&A mean?
- Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.
Ask your AI about National Health Investors's d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude